Table 5 Patients with stable disease (RECIST) for at least 4Â cycles of treatment with dinaciclib
Subject number | Diagnosis | Dinaciclib dose level (mg/m2) | Number of prior treatment regimens | Response by RECIST | Number of cycles |
|---|---|---|---|---|---|
2902 | NSCLC | 0.66 | 16 | SD | 6 |
2910 | Pseudomyxoma peritonei | 2.59 | 3 | SD | 9 |
2913 | Prostate cancer | 3.63 | 2 | SD | 4 |
2920 | Melanoma | 3.63 | 3 | SD | 10 |
2926 | Sarcoma | 7.11 | 2 | SD | 12 |
2928 | Gastrointestinal stromal tumor | 7.11 | 2 | SD | 10 |
2931 | Esophageal carcinoma | 7.11 | 3 | SD | 11 |
2932 | Adenoid cyst carcinoma | 7.11 | 0 | SD | 5 |
2937 | Adenoid cyst carcinoma | 14.0 | 3 | SD | 8 |
2945 | NSCLC | 12.0 | 4 | SD | 4 |